
[Cancer Research 60, 6510-6518, November 15, 2000]
© 2000 American Association for Cancer Research
Clonal Selection versus Genetic Instability as the Driving Force in Neoplastic Transformation1
Ming Chow2 and
Harry Rubin3
Department of Molecular and Cell Biology and Virus Laboratory, Life Sciences Addition, University of California, Berkeley, California 94720-3200
 |
ABSTRACT
|
|---|
Recent clonal studies of spontaneous neoplastic transformation in cell
culture indicate that it develops at confluence in a small minority of
individual clonal populations before it does in the uncloned parental
culture. Either preferential selection of spontaneous variants or
genetic destabilization in clones can be inferred to explain the
result. In the present experiments, using a subline of NIH 3T3 cells
that is relatively refractory to transformation, we demonstrate
unequivocally that transformed foci appear under selective conditions
in some clones long before there is any sign of neoplastic change in
the polyclonal culture from which they were derived. Because the
transformed cells that appear in the susceptible clones are not
inhibited in the size or number of foci formed on a confluent
background of the uncloned parental population, the genetic events
underlying transformation must occur much less frequently in the
latter. This disparity can be accounted for by the much larger number
of selectable cells in the susceptible clones at confluence than in the
parental culture, where such cells are a minority. The preferential
transformation exhibited by experimental isolation and expansion of
susceptible clones accords with evidence from various sources that
neoplastic transformation in culture is a multistep process dependent
primarily on selection of spontaneously occurring genetic variants.
There is no necessity to posit a significant role for genetic
destabilization in neoplastic transformation. These considerations
bolster computer models of human cancer that implicate selective
expansion of rogue clones rather than genetic instability as the
driving force in the origin of most tumors. Both the genetics of the
selected clone and the epigenetics of the selective environment would
then contribute to tumor development.
 |
INTRODUCTION
|
|---|
It is well established that most human cancers are of monoclonal
origin (1, 2, 3, 4)
. Given the nature of neoplastic growth,
selection is an intrinsic factor in the expansive growth of the progeny
of a single cell that produces a tumor. In recent years there has been
an emphasis on genetic instability as the driving force in the
development of cancer (5)
. Much of this emphasis can be
attributed to the multistep progression of cancer and the conventional
estimates of normal somatic mutation rates that are far too low to
account for its incidence (6)
. It was suggested that a
mutator phenotype arises in which the rate of mutation is greatly
increased. Mutations in mismatch repair genes do in fact raise the rate
of mutation, particularly in simple sequence repeats, and underlie
hereditary nonpolyposis colorectal cancer (7)
.
Defects in mismatch repair do not, however, precede the
APC4
mutations which provide the selective growth advantage that
initiates most cases of the much more prevalent sporadic type of
colorectal cancer (8
, 9)
. Computer modeling indicates that
selection is the driving force in the initiation of most human cancers
and genetic instability is a late event in their development (10
, 11) . On this basis, mutation that confers selective growth
advantage would be considered the critical event in the origin of
cancer.
Although the studies of the genetics of human cancer have
highlighted the role of selection, they provide little information on
the dynamics of the process. However, studies of spontaneous neoplastic
transformation in cell culture provide considerable insight on the
subject. The first indication that selection plays a role in
spontaneous transformation came from studies of the adaptation of mouse
embryo fibroblasts to cell culture, which revealed that there were
large increases in saturation density after multiple passages of cells
at high density (12)
. Because the multiplication of normal
cells is inhibited by contact at high population density, it appeared
that there was selection of variants that overcome that inhibition, a
characteristic of neoplastic cells. The role of selection was supported
by the finding that mouse embryo fibroblasts passaged at high density
gained the capacity to produce sarcomas in syngeneic mice within 3
months, whereas those passaged at low density did not become
tumorigenic through the entire 9 months of the study (13)
.
Additional support for selection as the driving force in spontaneous
transformation came from findings that it was produced in established
lines of mouse fibroblasts by procedures that selectively inhibit the
multiplication of normal cells, such as suspension in soft agar
(14)
, long-term contact inhibition in confluent cultures
(15)
, or reduced growth rate in either low serum
concentration (16)
or in fetal serum with suboptimal
growth-supporting activity (15
, 17)
.
All of the foregoing studies used fibroblasts, but most human cancers
are of epithelial origin (18)
. It is therefore of
particular significance for human cancer that selective conditions were
found to promote transformation in epithelial cells. Diploid rat liver
epithelial cells kept in a stationary state at confluence for 3 weeks
between every monthly passage gained the capacity in only 20 cell
divisions to produce liver carcinomas in syngeneic rats, whereas those
passaged weekly before they became confluent did not produce tumors
until they had undergone about 6 times as many divisions
(19)
. A significant sidelight occurred when the liver
epithelial cells were treated with a mutagenic carcinogen before being
cultured under selective and nonselective conditions. The treated cells
became tumorigenic under both regimes at about the same disparate times
as they had in spontaneous transformation, indicating that selection
was the dominant force in transforming carcinogen-treated cells as
well. Indeed, the carcinogen seemed to add little to the spontaneous
variation that provided the altered cells for selection. There was no
correlation between aneuploidy and tumorigenicity in the spontaneously
transformed populations: populations of aneuploid cells often were
nontumorigenic. However, there was a correlation in the
carcinogen-treated cells, indicating that the carcinogen treatment
produced a specific type of aneuploidy that was associated with
carcinogenesis.
The question of selection versus genetic instability arose
again in spontaneous transformation of the NIH 3T3 line of mouse
fibroblasts. Cells from the original transformation-sensitive stock of
NIH 3T3 cells gave rise to clones among which there was a small
minority that started to produce a few dense transformed foci at
confluence sooner than the polyclonal population from which the clones
were derived (20)
. When six of the clones were cocultured
before the first round of confluence, they produced many fewer dense
foci in subsequent rounds than expected from averaging the number that
occurred in parallel cultures of the individual clones
(21)
. It was proposed that the individual clones were
genetically unstable, and intimate contact with other clones stabilized
them. We pursued this proposal further in the present study using
clones of a subline of NIH 3T3 cells that is relatively
refractory to spontaneous transformation. We report that a minority of
the clones produced well-defined transformed foci well before there was
any sign of transformation in the uncloned parental culture. A
quantitative analysis of the results shows that the disparity can be
fully accounted for by the much smaller number of transformable cells
from the susceptible clones in the polyclonal parental population at
confluence than there are in each susceptible clone at confluence.
Simple numerical accounting thus eliminates the need for the arbitrary
assumption of genetic destabilization by clonal isolation to explain
preferential transformation in the minority of clones that were
susceptible.
This conclusion, of course, concurs with William of Ockhams maxim,
"Multiplicity ought not to be posited without
necessity," otherwise known as Occams Razor.
 |
MATERIALS AND METHODS
|
|---|
The A' cells used here are a transformation-resistant subline
(20)
of the original NIH 3T3 line of mouse embryo cells
(22)
. They were derived by 146 LDPs from the primal stock
of NIH 3T3 cells. The original transformation-sensitive stock of NIH
3T3 cells (which we designated SA') as well as its clones readily
underwent progressive neoplastic transformation in serial rounds of
incubation at confluence in a standard assay for transformed foci
(15
, 20) . By contrast, the A' subline was difficult to
transform under these conditions (23)
and in the present
experiments failed to exhibit unequivocal focus formation through many
serial rounds of the standard assay. Cells were maintained by LDPs of
5 x 103 cells in
21-cm2 plastic culture dishes. The growth medium
was MCDB 402 (24)
, containing 10% CS vol/vol. A primary
(1°) assay for transformed focus production was done by seeding
105
cells in MCDB 402 with 2% CS, and incubating
the cultures for 14 days with medium changes every 34 days. The cells
grew to confluence in 45 days, and remained at confluence with no
further increase in cell number between 7 days and the end of the assay
at 14 days. Under this selective condition, progressively transforming
and fully transformed cells continued to multiply to form foci of
overlapping cells interspersed among the surrounding monolayered
population. Secondary (2°) assays were duplicates of the 1° assay
using sister cultures of the latter, and further serial assays up to
the sixth (6°) assay were done in the same way using cells from the
termination of the previous assay. In some of the later serial assays,
when heavy transformation was expected, 104
or
103 cells were also diluted with
105
nontransformed uncloned A' cells from the
LDPs that had never been at confluence. Some assays were deliberately
prolonged by extending the incubation period to 28 days. The cell count
at the end of each serial assay represented the saturation density of
the culture.
The cells were cloned by seeding an average of one cell/well in 96-well
plates (Falcon 3072) with growth medium MCDB 402 plus 10% CS vol/vol.
The approximate number of cells/well was monitored under the microscope
and recorded at 2, 4, 5, and 6 days. Wells containing more than one
colony were excluded. Clones were designated by the coordinate position
of the well they occupied. Twenty-seven clones were harvested by
trypsinization at 5, 6, and 7 days and divided into five groups, as
shown in Figs. 1
-3, depending on their initial growth rates as estimated from the cell
number in the wells. The clones were expanded in
21-cm2 dishes and subcultured five times in
LDPs of 5 x 103 cells/dish
every 4 days. The uncloned cells were maintained in parallel with the
clones by the same LDPs. The growth rate of each clone and of the
uncloned culture was estimated by the cell yield at each passage. At
the fifth passage, an aliquot of the cells was used to initiate the
first set of six serial assays at confluence for transformation, and
the remaining cells were used to continue the LDPs. At the 13th LDP, a
second set of four serial transformation assays was initiated.

View larger version (31K):
[in this window]
[in a new window]
[Download PPT slide]
|
Fig. 1. Growth rates of clones and uncloned culture in first four
LDPs. The growth rates of every clone in the five groups were estimated
in each of the first four LDPs by dividing the yield of 4 days by the
number of cells seeded and converting the value into PD/D. Parallel
determinations were made in LDPs of the uncloned A' culture. The
results are shown by group, and the A' cells are recorded with group 2
in a broken line. Bars, variation between two
independent measurements at each point.
|
|
The growth rate of every clone was determined after the first and
second serial assay of the first set and after each of three additional
assays for groups 2 and 5. Growth rates were initiated with the cells
from the confluent assays culture by passaging them once at low density
(5 x 103 cells/dish) for 2 days
to recover from contact inhibition, and passaging them again at low
density into 4 culture dishes. Two of the cultures were counted at 1
day and another two at 4 days. These measurements of growth rate were
done in parallel with similar ones of cells from the regular LDPs that
had never experienced crowding. Growth rates were calculated as
PD/D. The relative growth rate of cells recovered from the
confluent assay cultures was determined by dividing its PD/D by that of
the control LDP cells. All measurements of growth rate of the clones
were accompanied by the same measurements of the uncloned culture.
The best description of their morphology comes from viewing photographs
of selected clones and the uncloned culture. Those confluent assay
cultures that were not trypsinized for passage or growth rate
determinations were fixed with Bouins reagent and stained with 4%
Giemsa buffered at pH 7.0 to determine the extent of transformed focus
formation. As is documented with photographs (e.g., Fig. 4
),
the uncloned culture produced no discernible foci in the first set of
serial assays, but many of the clones did. However, the foci produced
by the A' clones did not reach the large size and high cell density of
those produced by the transformation-sensitive SA' cells in our
previous studies (20
, 23
, 25)
. The scale used to
characterize the degree of morphological transformation is shown in
Fig. 6
. Where the transformation was particularly strong, it resulted
in a marked increase in saturation density of the assay culture.

View larger version (48K):
[in this window]
[in a new window]
[Download PPT slide]
|
Fig. 4. Preferential progressive transformation in clones and
their capacity to produce transformed foci on a confluent background of
uncloned A' cells. A, 105 cells of all of
the clones and of the uncloned A' culture were seeded in six serial
assays at confluence of the first set. Assays 1°, 4°, and 6° of
clones 1a, 2e, and the uncloned cells are shown. B,
104 cells from the 6° assay of all of the clones and of
the uncloned A' culture were mixed with 105 cells of the
standard LDP of the A' cells and seeded for assays at confluence. The
assay of clones 2e and 10c and the uncloned A' cells with a background
of LDP A' cells are shown, as is the assay of 105 LDP cells
by themselves at the lower right.
|
|

View larger version (80K):
[in this window]
[in a new window]
[Download PPT slide]
|
Fig. 6. Scale of transformation of clones and the uncloned A'
culture from the 6° assay of the first set. The assays were initiated
with 105 cells in the left column, and
104 cells mixed with 105 cells of LDP uncloned
A' cells in the right column. This was
the first assay in which the uncloned A' cells exhibited any sign of
transformation, although it was in the (±) category. Only the + and ++ categories produced distinct foci in the mixture of
104 cells with 105 LDP uncloned A' cells.
|
|
 |
RESULTS
|
|---|
Growth Rates of Clones in First Four LDPs.
Fig. 1
shows the growth rates of the cells in every clone during the
first four LDPs arranged according to group number. The clones of group
1 were relatively uniform with a group-averaged growth rate of
1.85 ± 0.08 PD/D (the "±" part is "the average
of the absolute deviations of data points from their mean"). Four of
the group 2 clones multiplied relatively rapidly (averaged
1.86 ± 0.14 PD/D), but two of them (6 h averaged
1.27 ± 0.07 PD/D, and 8 h averaged 1.57 ± 0.03 PD/D) were distinctly slower than the rest. The uncloned
A' culture was kept with group 2 and had a consistently high growth
rate (averaged 1.90 ± 0.09 PD/D). There was a wide
spread in the growth rates of groups 3, 4, and 5 (1.64 ± 0.17 PD/D, 1.74 ± 0.14 PD/D, and 1.49 ± 0.27 PD/D, respectively) with group 5 exhibiting the slowest
growers. The rank order of growth rates of individual clones in each
group was mostly consistent throughout the four passages, indicating
that they represented heritable differences between the clones.
Reduction in Growth Rates of Clones Subcultured after Serial Assays
at Confluence.
Table 1
shows the average growth rates for each group of clones as well as the
uncloned culture for the LDPs and for cells recovered from the first
two serial assays. Experimental cells of all groups showed a decrease
in growth rate after the assays at confluence despite the fact that
they were given a 2-day passage at low density to recover from the
constraint of confluence before passage for growth rate determination.
The extent of reduction after the 1° assay varied from 18 to 25% for
the clones, and 15% for the uncloned culture. The relative reduction
was apparently less after the 2° assay. However, a close inspection
of the data shows there was an anomalous drop in the growth rate of the
LDP controls of some clones rather than a rise in the growth rates of
their experimental counterparts. The results were consistent with the
idea that the prolonged period of constraint at confluence inflicts
heritable damage on the cells (23
, 26)
.
View this table:
[in this window]
[in a new window]
|
Table 1 Reduction in growth rates (PD/D) of clones and their uncloned parental
culture after recovery from confluent assays
Cells were passaged at low density after the 1° and 2° assays at
confluence, incubated for 2 days to recover from confluence, then
passaged again at low density to determine growth rates (Column III).
Cells from LDPs of each clone and from the uncloned parental culture
were used as controls (Column II). The average PD/D and standard
deviations for each group of clones are shown for the 1° and 2°
assays of the first set, and the ratio of the post-assay growth rate to
LDP growth rate is in the last column.
|
|
Fig. 2
shows the relative growth rates of groups 2 and 5 through the 5°
assay at confluence. With the exception of clone 8a of group 2 and
clones 8b and 5c of group 5, all of the clones and the uncloned culture
exhibited reduced growth rates after assay at confluence. However, the
heritable damage implied by these results showed no correlation with
the extent of transformation described below, particularly in the case
of the uncloned culture that showed no evidence whatever of
transformation in the first five assays at confluence.

View larger version (30K):
[in this window]
[in a new window]
[Download PPT slide]
|
Fig. 2. Relative growth rates of clones subcultured after serial
assays at confluence. After each serial assay of the first set, some
cells from the clones of groups 2 and 5 were passaged once at low
density for 2 days to allow recovery from the inhibitory effects of
confluence, then passaged again to determine their growth rates over a
4-day period at low density. The growth rates of the uncloned A' cells
were determined in the same way after parallel assays. At the same
time, the growth rates of the clones and uncloned cells from the LDPs
that had never been confluent were determined. The ratios of the growth
rates of the post-assay cells and the LDPs are shown. The uncloned A'
cells are represented in a broken line. Bars, total
variation made up of individual variations in the cell counts of
experimental and control cultures.
|
|
Saturation Densities of Clones in Serial Assays at
Confluence.
Fig. 3
shows the saturation densities after each of the six assays of the
first set. The uncloned culture (dotted line in group 2) had
a higher saturation density (6 x 105
) than any clone in the 1° assay, but it
dropped to half that value in the 2° assay and remained at that low
level for all of the subsequent assays. It produced no foci up to the
6° assay, when some very faint foci appeared (Fig. 4)
. Clone 1a of group 1 showed a steady increase in saturation density
between assays 3° and 6° with a final value above
106 cells/culture in the final assay. This was
consistent with the appearance of many small foci in clone 1a beginning
in the 3° assay. Clone 10c of group 2 exhibited a marked increase in
saturation density between the 5° and 6° assay, when it went from
producing a small number to a large number of moderately dense foci.
Clone 9g of group 2 also increased significantly in saturation density
in the 6° assay as well as in the number of moderately dense foci.
Clone 6h displayed a more modest increase in saturation density in the
6° assay and had a large number of foci, but they were lighter than
those of 10c and 9g. In group 3, clone 2c increased steadily in
saturation density between assays 3° and 6° just as clone 1a of
group 1 had. This was in keeping with a large increase in the number of
moderately dense foci. The only clone in groups 4 and 5 to show a
significant increase in saturation density was clone 11a. It had
already produced a few light foci in the 1° assay. These became
denser and larger in the 3° assay and increased in number in the
4°, 5°, and 6° assays, which had increases in saturation density.
Fig. 3
, bottom right, also shows the average and SE of
saturation densities for all of the clones that began to exceed that of
the uncloned culture in the 4° assay. Whereas the saturation density
measurements of the late assays showed prominent increases for five of
the clones with no increase for the uncloned culture, it was evident by
inspection that many clones were producing visible foci that did not
result in saturation density increases. An elementary way to document
this, which captures the essence of the phenomenon that more
sophisticated measurements cannot, was through photographs of the
culture dishes. These included cultures from the first set of six
serial assays and cultures from a second set of four serial assays as
described below.

View larger version (35K):
[in this window]
[in a new window]
[Download PPT slide]
|
Fig. 3. Saturation densities of clones in serial assays at
confluence. The number of cells were counted at the end (1415 days)
of each of six serial assays at confluence of the first set for every
clone and the uncloned A' cells. The saturation densities are separated
by group and the A' cells are recorded with group 2. The bottom
graph on the right shows the averages of the clones from each
assay and the values for the uncloned A' cells. Broken
line in group 2 and bottom graph, uncloned A'
cells.
|
|
Visual Demonstration of Preferential Progressive Transformation in
Clones.
Fig. 4A
illustrates progressive transformation in 2 clones
(1a and 2e) and its absence in the uncloned A' parental cells spanning
six serial assays of the first series. Clone 1a was negative in the
1° assay, and began showing light foci in the 3° assay (not shown);
the light foci became confluent with one another in the 4° assay, and
progressed to small, dense foci on a confluent background of light foci
in the 6° assay. Clone 2e was also negative in the 1° assay but
began to produce light foci in the 2° assay (not shown) that
progressed to discrete, moderately dense foci in the 4° assay and to
dense foci on a confluent background of lighter foci in the 6° assay.
The background of light foci was not as thick as that of clone 1a in
the 6° assay, which was reflected in the higher saturation density of
the latter (Fig. 3)
. The uncloned A' cells remained completely negative
through the 5° assay but exhibited scattered, small, light foci in
the 6° assay. The results indicate that the diverse cells of the
uncloned parental culture, which must have contained many cells similar
to those of clones 1a and 2e, underwent much less transformation than
those clones.
We entertained the possibility that some transformation was occurring
in the uncloned culture but was not expressed because of
growth-suppressing interactions among the diverse cells of this
polyclonal mixture that did not occur in the more homogeneous clones.
To investigate this possibility, the individual clones and the uncloned
parental cells were diluted for the 6° assay, and
104
cells were seeded together with a 10-fold
excess of 105
A' LDP cells to form a confluent
nontransformed background for the display of foci from the cloned
cells. Representative results are illustrated in Fig. 4B
, in
which clones 2e and 10c produce distinct transformed foci; but the 6°
assay of A' cells shows no evidence of focus formation on a background
of A' LDP cells. The 10c clone had produced small numbers of light foci
with 105
cells in the 4° and 5° assay, but
did not exhibit a significant increase in saturation density until the
6° assay, in which even 104
cells produced a
large number of foci. A culture of the LDP A' cells that formed the
background for the 6° assay cells is also shown. It is evident that
foci appeared in the 6° assay of the clones on the same background on
which the 6° assay of the uncloned population failed to produce foci.
This provides unequivocal evidence that the events that underlie
transformation simply had not occurred in the uncloned culture to
nearly the same extent as they had in some of its derivative clones.
We then examined the effect of extending the period of confluence to
determine whether foci would develop in cultures that were negative in
the standard 14-day assay period and also to reveal expansion or
progression of foci that were already apparent at 14 days. The extended
assay was done with cells from the second set of serial assays and
representative results can be seen in Fig. 5
. The foci present in clone 2e at 14 days increased in size at 28 days,
indicating the selective growth advantage of cells in the foci. Clone
4b exhibited no foci at 14 days, but a few moderately dense foci and
many small, light ones could be seen at 28 days, indicating either slow
growth of the transformed cells in this clone or delayed onset of
transformation. The uncloned A' cells failed to display any foci at
either 14 days or 28 days. The clone 2c cultures at the
bottom of Fig. 5
were from a later assay of the second set
and showed development from light to dense foci between 14 and 28 days.
The results show the diversity of dynamics of focus formation among the
clones and reinforce the evidence of greatly reduced transformation in
the uncloned population relative to some of its clones.

View larger version (77K):
[in this window]
[in a new window]
[Download PPT slide]
|
Fig. 5. Effect on focus formation of extending the assay at
confluence to 28 days. The top three pairs are from the
2° assay of the second set; the bottom pair is from
the 4° assay of the second set. Some cultures were fixed and stained
at the standard assay time of 14 days and others at 28 days, as
indicated.
|
|
Overall Trends in Transformation among All of the Clones in the
First Two Sets of Serial Assays.
The degree of transformation of every clone and of the uncloned
population was classified in each assay of the first two series
according to the scale in Fig. 6
. The scale of transformation is based on the seeding of
105
cells in each assay but was elaborated in the
later assays by seeding 104
cells with an excess
(105
) of nontransformed cells from the LDPs of
the uncloned A' cells. In those cases which included assays for
104
cells, the classification in the relatively
strong (++) and moderate (+) categories for 105
cells was reinforced by the appearance of discrete foci in the assay of
104
cells, which were not seen in the weak (±)
category. The graphs in Fig. 7
show an increase in the number of transformed clones in each category
with successive serial assays. About half of the clones had
moderate-to-relatively strong transformation in the last two assays of
the first series, whereas the uncloned A' cells were negative through
assay 5° and only weakly transformed in assay 6°.
The proportion of clones in all categories of transformation was higher
in all of the second set of assays than in comparable assays of the
first set, indicating some progression during the eight additional LDPs
between the beginning of the first and second sets. The uncloned
culture was negative in assays 1° and 2° of the second series, but
exhibited variable low-level transformation in assays 3° and 4°.
Hence, some transformation appeared in the polyclonal parental culture
of the second set of assays at an earlier point than it did in the
first set and was associated with earlier transformation among the
clones. However, the parental transformation was at a much lower level
than might be expected from the fact that one-third of the clones
already exhibited relatively strong transformation in the 3° assay,
and there would have been many thousands of such clones in the assay of
105
cells of the parental culture. The apparent
paucity of well-defined foci in the parental culture will be analyzed
below in terms of the minority fraction of productive cells as compared
with the number in some isolated clones. In this regard, it is notable
that most of the clones that displayed unequivocal transformation in
the first set of assays did so in the second set, indicating that
transformability is a heritable property of the clones, although
subject to population drift in multiple LDPs (25)
.
 |
DISCUSSION
|
|---|
Our previous studies, which showed a higher rate of
confluence-mediated transformation in recently cloned cell populations
than in their polyclonal parental population (20
, 21)
,
left unresolved the possibility that the mixed population simply
suppressed the proliferation of transformed cells rather than somehow
avoiding the events that underlie transformation. Here we showed that
the transformed cells from about one-fifth of the clones produced
characteristic multilayered foci against a confluent background of the
nontransformed polyclonal parental population. (See Figs. 4B
and 6
.) Hence, in the regular seeding of 105
cells of the uncloned parental population in the assay for focus
formation, there would be at least 2 x 104
cells capable of undergoing and clearly
exhibiting transformation if they were cultured as isolated clones, yet
no clearly identified transformed foci were detected in six serial
assays at confluence. The absence of such foci in the polyclonal
parental population indicates that some feature of the clonal mixture
reduced the number of genetic changes/culture that underlie the
transformation seen in cultures of the isolated clones. This conclusion
is augmented by the finding of large increases in saturation density of
a number of clones with successive rounds of confluence when there was
no such increase in the polyclonal population (Fig. 3)
. The failure of
focus formation in the polyclonal population persisted even when the
incubation period of the assay was increased from 14 to 28 days,
whereas the foci initiated in the clonal cultures were
increasing in size and number.
In isolating clones and expanding them to large populations in the
selective assay at confluence for transformed foci, we increase the
number of cells originating from a single cell in comparison with the
number of clonally related cells in a polyclonal population. That is,
the ratio of cell numbers in any particular clone at saturation density
to the number of phenotypically similar cells in the polyclonal
population is inversely proportional to the fraction of those clones in
the polyclonal population. If we take as a class of clones, for
example, those which eventually produce well-defined ++ transformed
foci (Fig. 6)
, an isolated clone of that class will reach confluence
with a much larger number of potential focus formers than the total
number of similar cells in the polyclonal population, in inverse
proportion to the fraction of ++ focus-forming clones among all clones
in the latter population. The smaller the fraction, the larger is the
differential. There were 5 of 27 clones that consistently produced ++
foci in the last three assays of the first set, or roughly one-fifth
the total number of clones. Therefore, the total number of ++ focus
producers in the polyclonal population at confluence will be about
one-fifth of the number in each of the isolated ++ clones at
confluence. The saturation density of each of the cloned and uncloned
cultures remains roughly constant between 2 and 4 x 105
cells during the first few assays (Fig. 3)
.
Because the production of foci is dependent on the number of
focus-forming cells at confluence, the isolated clones with the
potential for producing ++ foci would be expected to display such foci
in a much earlier assay than the polyclonal population. Well-defined
focus production first appears in two clones in the 3° assay of the
first set, and reaches a plateau of five consistent focus producers in
the 4° assay. The failure of such foci to appear in the polyclonal
population in any of the six assays of the first set (nor in any assay
of the second set) follows from the 5-fold reduction in number of
potential ++ cells in that population compared with the number in each
isolated clone. According to this crude estimate, it would take at
least 15 serial assays of the polyclonal population to produce foci of
the ++ type. A similar calculation can be made for the combined number
of + and ++ focus-producing clones, which constitute about
half of the total number of clones, e.g., if there had been
a large number of polyclonal cultures, and the number of serial assays
extended beyond six, a fraction of them might be expected to exhibit
foci by the 7° assay. If we include the somewhat marginal and
sometimes transient ± focus-forming clones in the
total, which reaches about half its maximum at about the 3° assay, it
is not surprising that some weak foci appear in the polyclonal
population by the 6° assay. Similar analysis can be applied to the
second set of assays in Fig. 7
. Therefore, the relative ease with which
the clonal populations are transformed compared with the polyclonal
parental population can be explained simply in terms of clonal
diversity in the latter.
In earlier papers using the original transformation-sensitive line that
produced large, dense foci (20
, 21)
, and particularly
where six isolated clones were compared with a mixture of the six
clones, we found that some of the isolated clones progressed to dense
focus formation before any were seen in the mixture (21)
.
This was interpreted by assuming that isolated clones were genetically
unstable at confluence, and that they were stabilized by metabolic
cooperation with one another in the mixture, thereby preventing early
steps in progression. The simpler explanation is that only three of the
six clones progressed to dense focus formation in the 2° assay and
did so at different rates. According to the inverse proportionality
between a cloned and uncloned population in the number of potential
focus-formers established above, there would be a 2-fold reduction of
potential focus-formers in the mixture with a proportionate delay in
focus formation to assays beyond those done in the experiment.
Because the argument of clonal diversity fully accounts for the paucity
of foci in the polyclonal parental culture, the previous hypothesis of
clonal destabilization is unnecessary. In fact, there is no independent
verification that clonal isolation results in an increase in the rate
of transformation-related variation. This possibility had been
considered (20
, 21)
because transformation was frequently
associated with a heritable reduction in the growth rate of cells at
low population density (26, 27, 28)
, which could be ascribed
to genetic damage with accompanying mutations. However, selection of
progressively transformed cells by LDP in low CS concentration
(16)
or fetal bovine serum (15
, 17) does not
result in a reduction in growth rate. A complementary negative finding
is that the heritable reduction in growth rate induced by methotrexate
treatment of NIH 3T3 cells does not produce transformation
(29)
. Perhaps more cogently, treatment of diploid liver
epithelial cells with a mutagenic carcinogen only marginally increased
their spontaneous rate of transformation under selective conditions and
had no significant effect on the rate of transformation under
nonselective conditions (19)
. Whereas we cannot exclude a
role for genetic destabilization in transformation for all conditions,
there is no reason to postulate such a role in the present case because
the preferential transformation of minority clones can be fully
accounted for by the selection and expansion of susceptible cells.
Additional evidence against the destabilizing effect of clonal
isolation is the existence of some clones even in the
transformation-sensitive subline of NIH 3T3 cells that fail to
transform in many repeated rounds of selection (25)
as
well as the many that show no transformation or only marginal effects
in the present experiments (Fig. 7)
.
The conditions in culture for selective growth of cells in various
stages of transformation are those which preferentially inhibit
multiplication of nontransformed cells. We achieved artificial
selection in the present paper by isolating and expanding clones, a few
of which were particularly susceptible to confluence-mediated
transformation. The contact inhibition of confluent cultures was also
used to drive selection of spontaneous transformants in a line of
diploid liver epithelial cells (19)
. Because all
epithelial cells in the organism are in direct contact with their
homotypic neighbors, confluence per se does not act as a
selective force for carcinoma development in vivo. In the
case of colorectal cancer in humans, biallelic mutations at the APC
locus apparently confer selective advantage on stem cells in the
colonic crypt, which allows them to continue to multiply above the
bottom two-thirds of the crypt and thereby to form dysplastic adenomas
(7
, 30)
. The particular mutations that underlie selection
in culture are unknown. The differences in morphology of transformed
foci (20
, 31)
and the number of steps in transformation
(32)
indicate that many genetic loci are involved in the
process. The effect of these mutations in culture is formally the same
as that of APC in the colon in that both endow selective advantage to
the cells under conditions that regulate the multiplication of normal
cells. Rapid exponential multiplication of cultured cells minimizes or
even selects against transformation (17)
, perhaps because
transformed cells tend to multiply, when unconstrained, at a lower rate
than nontransformed cells (26, 27, 28)
. The only parallel
in vivo might be the relatively unconstrained cell growth of
early embryogenesis during which tumor development is minimized.
Another form of selection for transformation in culture is to lower the
concentration of growth factors while maintaining exponential growth at
low population density (16
, 17)
. The corollary in
vivo would be a long-term reduction in the concentration of a
hormone that stimulates cell multiplication. Accordingly it has been
suggested that the diminution of testosterone production that occurs in
aging men selects for testosterone-independent cells and contributes to
the steep increase in prostate cancer beyond the age of 50
(33)
. It has also been pointed out that deprivation of
estrogenic hormones, which produces regression of spontaneous mammary
tumors in mice, eventually results in progression of the residual
neoplasia to a hormone-independent state (34)
.
Selection also plays a role in chemical carcinogenesis of experimental
animals. Farber has proposed the resistant hepatocyte model of liver
carcinogenesis based on the findings that the cells in early stages of
tumor development multiply in the presence of a carcinogen which
is inhibitory to the growth of the normal hepatocytes (35)
. There are a
number of cases in rodents in which carcinogens apparently select for
the growth of cells with preexisting mutations in ras
genes (36
, 37)
. Long-term repeated applications of
nonmutagenic promoters alone give rise to a few liver tumors (38
, 39)
which apparently result from selection of preexisting
enzyme-altered cells that have a defect in growth control (39
, 40)
. The compensatory hyperplasia that is an early step in
experimental carcinogenesis of the skin (41)
and colon
(42)
may also favor clonal expansion of cells that are
defective in growth control and thereby promote the accumulation of
mutations associated with progression.
If selection is to play the dominant role in carcinogenesis, there
must, of course, be sufficient rogue clones from which to select. It
was recently pointed out that conventional estimates of mutation
frequencies in normal tissues may be far too low (43)
. For
example, 1 of 4,000 normal kidney cells in aging men was found to have
a mutation at the X-linked HPRT locus (44)
,
which encodes a much smaller gene than many tumor suppressor genes
(43)
. Thus biallelic mutations of tumor suppressor genes
may not be uncommon in normal tissues; mutations in micro- and
minisatellites, some of which occur within functional genes, occur at
much higher rates. There are enough cell divisions of normal intestinal
stem cells and growing tumors to account for the 11,000 mutations/cell
reported in colorectal polyps and carcinomas (45)
without
inferring an increased mutation
rate.5
Simpson (43)
suggests that the aging human body
accumulates enough mutations to account for multistep carcinogenesis by
selection of preexisting mutations. This would be especially true if
selective conditions for clonal expansion were heightened with age. One
indication that this is the case is that rat hepatocarcinoma cells are
much more tumorigenic when inoculated into the liver of old rats than
into that of young rats (46)
. Another indication of
tissue-wide changes with age is the slowdown in multiplication rates of
intestinal mucosa accompanied by a large increase in heterogeneity
among the crypt cells in the onset of DNA synthesis (47
, 48)
.
In fact, the combination of accumulated mutations and disturbances of
the regulatory environment associated with aging raises the question of
why cancer is not more common than it is. It may be that the normal
architecture of a tissue maintains a regulatory environment that keeps
rogue clones behaving normally or disposes of them by apoptosis. This
would be in keeping with the first principle of Elsassers theory of
organisms, which postulates that "there can be regularity in the
large where there is heterogeneity in the small: order above
heterogeneity" (49)
. This elementary principle has
been expressed as macrodeterminism in developmental biology
(50)
and as holistic control of neuronal excitation in the
brain (51)
. A classical example is the teratocarcinoma of
mice that is produced when young mouse embryos are grafted into the
testes of adult mice (52)
: inoculation of core cells of
the teratocarcinomas into blastocysts results in their integration as
normal elements in chimeric tissues of many types, including
reproductively functional sperm (53)
. The primary
principle of ordered heterogeneity subsumes this behavior and several
other genetic and epigenetic aspects of the cancer problem
(54)
. It therefore provides a theoretical foundation to
account for the long-term stability of multicellular structures despite
the accumulation of many somatic mutations (55, 56, 57)
.
 |
ACKNOWLEDGMENTS
|
|---|
We thank John Cairns, Morgan Harris, Kenneth Kinzler, George
Klein, Lawrence Loeb, Darryl Shibata, David Sidransky, and Ian
Tomlinson for their helpful comments on the work and we thank Dorothy
M. Rubin for preparing the manuscript.
 |
FOOTNOTES
|
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by grants from the
Council for Tobacco Research and the Elsasser Family Fund. 
2 Present address: Gene Logic, Inc., 2001 Center
Street, Berkeley, CA 94704. 
3 To whom requests for reprints should be
addressed, at Department of Molecular and Cell Biology and Virus
Laboratory Life Sciences Addition, University of California, Berkeley,
CA 94720-3200. Phone: (510) 642-6617; Fax: (510) 643-6791; E-mail: hrubin{at}uclink4.berkeley.edu 
4 The abbreviations used are: APC, adenomatous
polyposis coli; LDP, low density passage; MCDB 402, molecular,
cellular, and developmental biology medium 402; CS, calf serum; PD/D,
population doublings per day. 
5 I. P. M. Tomlinson, personal communication. 
Received 3/15/00.
Accepted 9/12/00.
 |
REFERENCES
|
|---|
-
Fialkow P. J. Clonal origin of human tumors. Biochim. Biophys. Acta, 458: 283-321, 1976.[Medline]
-
Fearon E. R., Hamilton S. R., Vogelstein B. Clonal analysis of human colorectal tumors. Science (Washington DC), 238: 193-197, 1987.[Abstract/Free Full Text]
-
Sidransky D., Frost P., Von Eschenbach A., Oyasu R., Preisinger A. C., Vogelstein B. Clonal origin of bladder cancer. N. Engl. J. Med., 326: 737-740, 1992.[Abstract]
-
Bedi G. C., Westra W. H., Gabrielson E., Koch W., Sidransky D. Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res., 56: 2484-2487, 1996.[Abstract/Free Full Text]
-
Lengauer C., Kinzler K. W., Vogelstein B. Genetic instabilities in human cancer. Nature (Lond.), 396: 643-649, 1998.[Medline]
-
Loeb L. A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res., 51: 3075-3079, 1991.[Free Full Text]
-
Kinzler K. W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell, 87: 159-170, 1996.[Medline]
-
Young J., Leggett B., Gustafson C., Ward M., Searle J., Thomas L., Buttenshaw R., Chenevix-Trench G. Genomic instability occurs in colorectal carcinomas but not in adenomas. Hum. Mutat., 2: 351-354, 1993.[Medline]
-
Homfray T. F. R., Cottrell S. E., Ilyas M., Rowan A., Talbot I. C., Bodmer W. F., Tomlinson I. P. M. Defects in mismatch repair occur after APC mutations in the pathogenesis of sporadic colorectal tumours. Hum. Mutat., 11: 114-120, 1998.[Medline]
-
Tomlinson I. P. M., Novelli M. R., Bodmer W. F. The mutation rate and cancer. Proc. Natl. Acad. Sci. USA, 93: 14800-14803, 1996.[Abstract/Free Full Text]
-
Tomlinson I. P. M., Bodmer W. F. Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog. Nat. Med., 5: 11-12, 1999.[Medline]
-
Todaro G. J., Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol., 17: 299-313, 1963.[Abstract/Free Full Text]
-
Aaronson S. A., Todaro G. J. Basis for the acquisition of malignant potential by mouse cells cultivated in vitro. Science (Washington DC), 162: 1024-1026, 1968.[Abstract/Free Full Text]
-
Rubin H. Uniqueness of each spontaneous transformant from a clone of Balb 3T3 cells. Cancer Res., 48: 2512-2518, 1988.[Abstract/Free Full Text]
-
Rubin H., Xu K. Evidence for the progressive and adaptive nature of spontaneous transformation in the NIH 3T3 cell line. Proc. Natl. Acad. Sci. USA, 86: 1860-1864, 1989.[Abstract/Free Full Text]
-
Rubin A. L., Yao A., Rubin H. Relation of spontaneous transformation in cell culture to adaptive growth and clonal heterogeneity. Proc. Natl. Acad. Sci. USA, 87: 482-486, 1990.[Abstract/Free Full Text]
-
Rubin H. Adaptive evolution of degrees and kinds of neoplastic transformation in cell culture. Proc. Natl. Acad. Sci. USA, 89: 977-981, 1992.[Abstract/Free Full Text]
-
Rodriguez E., Sreekanitaiah C., Chaganti R. S. K. Genetic changes in epithelial solid neoplasia. Cancer Res., 54: 3398-3406, 1994.[Abstract/Free Full Text]
-
Lee L. W., Tsao M-S., Grisham J. W., Smith G. J. Emergence of neoplastic transformants spontaneously or after exposure to N-methyl-N'-nitro-N-nitrosoguanidine in populations of rat liver cells cultured under selective and nonselective conditions. Am. J. Pathol., 135: 63-71, 1989.[Abstract]
-
Chow M., Rubin H. The cellular ecology of progressive neoplastic transformation: a clonal analysis. Proc. Natl. Acad. Sci. USA, 96: 2093-2098, 1999.[Abstract/Free Full Text]
-
Chow M., Rubin H. Coculturing diverse clonal populations prevents the early-stage neoplastic progression that occurs in the separate clones. Proc. Natl. Acad. Sci. USA, 97: 174-178, 2000.[Abstract/Free Full Text]
-
Jainchill J. L., Aaronson S. A., Todaro G. J. Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells. J. Virol., 4: 549-553, 1969.[Abstract/Free Full Text]
-
Chow M., Rubin H. Relation of the slow growth phenotype and neoplastic transformation: possible significance for human cancer. In Vitro Cell. Dev. Biol. Anim., 35: 449-458, 1999.[Medline]
-
Shipley G. D., Ham R. G. Improved medium and culture conditions for clonal growth with minimum serum protein and for enhanced serum-free survival of Swiss 3T3 cells. In Vitro Cell. Dev. Biol. Anim., 17: 656-670, 1981.
-
Chow M., Rubin H. Clonal dynamics of progressive neoplastic transformation. Proc. Natl. Acad. Sci. USA, 96: 6976-6981, 1999.[Abstract/Free Full Text]
-
Rubin H., Yao A., Chow M. Heritable, population-wide damage to cells as the driving force of neoplastic transformation. Proc. Natl. Acad. Sci. USA, 92: 4843-4847, 1995.[Abstract/Free Full Text]
-
Reznikoff C. A., Bertram J. S., Brankow D. W., Heidelberger C. Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res., 33: 3239-3249, 1973.[Abstract/Free Full Text]
-
Smith G. J., Bell W. N., Grisham J. W. Clonal analysis of the expression of multiple transformation phenotypes and tumorigenicity by morphologically transformed 10T1/2 cells. Cancer Res., 53: 500-508, 1993.[Abstract/Free Full Text]
-
Chow M., Koo J. J., Ng P., Rubin H. Random, population-wide genetic damage induced in replicating cells treated with chemotherapeutic drugs. Mutat. Res., 413: 251-264, 1998.[Medline]
-
Lamlum H., Papadopolou A., Ilyas M., Rowan A., Gillet C., Hanby A., Talbot I., Bodmer W., Tomlinson I. APC mutations are sufficient for the growth of early colorectal adenomas. Proc. Natl. Acad. Sci. USA, 97: 2225-2228, 2000.[Abstract/Free Full Text]
-
Rubin H. Experimental control of neoplastic progression in cell populations: Foulds rules revisited. Proc. Natl. Acad. Sci. USA, 91: 6619-6623, 1994.[Abstract/Free Full Text]
-
Rubin H. Incipient and overt stages of neoplastic transformation. Proc. Natl. Acad. Sci. USA, 91: 12076-12080, 1994.[Abstract/Free Full Text]
-
Prehn R. T. On the prevention and therapy of prostate cancer by androgen administration. Cancer Res., 59: 4161-4164, 1999.[Abstract/Free Full Text]
-
Foulds, L. Neoplastic Development, Vol. 1. New York: Academic Press, 1969.
-
Farber E., Rubin H. Cellular adaptation in the origin and development of cancer. Cancer Res., 51: 2751-2761, 1991.[Free Full Text]
-
Brookes P. Chemical carcinogens and ras gene activation. Mol. Carcinog., 2: 305-307, 1989.[Medline]
-
Cha R. S., Thilly W. G., Zarbl H. N-nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hras 1 gene mutations. Proc. Natl. Acad. Sci. USA, 91: 3749-3753, 1994.[Abstract/Free Full Text]
-
Rossi L., Ravera M., Repetti G., Santi L. Long-term administration of DDT or phenobarbital-Na in Wistar rats. Int. J. Cancer, 19: 179-1977, 1977.[Medline]
-
Schulte-Hermann R., Timmermann-Trosiener I., Schuppler J. Promotion of spontaneous preneoplastic cells in rat liver as a possible explanation of tumor production by nonmutagenic compounds. Cancer Res., 43: 839-844, 1993.[Abstract/Free Full Text]
-
Ogawa K., Onoé T., Takeuchi M. Spontaneous occurrence of
-glutamyl transpeptidase-positive hepatcytic foci in 105-week-old and 72-week-old Fischer 344 male rats. J. Natl. Cancer Inst., 67: 407-412, 1981.
-
Cramer W. The early stages of carcinogenesis by 20-methylcholanthrene in the skin of the mouse. II. Microscopic tissue changes. J. Natl. Cancer Inst., 2: 379-402, 1942.
-
Chang W. Histogenesis of DMH-induced colon neoplasms in the mouse. J. Natl. Cancer Inst., 60: 1405-1418, 1978.
-
Simpson A. J. G. A natural somatic mutation frequency and human carcinogenesis. Adv. Cancer Res., 71: 209-240, 1997.[Medline]
-
Martin G. M., Ogburn C. E., Colgin L. M., Gown A. M., Edland S. D., Monnat R. J. Somatic mutations are frequent and increase with age in human kidney epithelial cells. Hum. Mol. Genet., 5: 215-221, 1996.[Abstract/Free Full Text]
-
Stoler D. L., Chen N., Basik M., Kahlenberg M. S., Rodriguez-Bigas M. A., Petrelli N. J., Anderson G. R. The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc. Natl. Acad. Sci. USA, 96: 15121-15126, 1999.[Abstract/Free Full Text]
-
McCullough K. D., Coleman W. R., Smith G. J., Grisham J. W. Age-dependent induction of hepatic tumor regression by the tissue microenvironment after transplantation of neoplastically transformed rat liver epithelial cells into the liver. Cancer Res., 57: 1807-1813, 1997.[Abstract/Free Full Text]
-
Lesher S., Fry R. J. M., Kohn H. I. Age and the generation time of the mouse duodenal epithelial cell. Exp. Cell Res., 24: 334-343, 1961.
-
Fry, R. J. M., Tyler, S. A., and Lesher, S. In: P. J. Lindop and G. A. Sacher (eds.), Relationships between Age and Variability, pp. 4355. Semmering, Austria: Taylor & Francis, Ltd., 1966.
-
Elsasser, W. M. Reflections on a Theory of Organisms. Baltimore: Johns Hopkins University Press, 1998.
-
Weiss, P. The Science of Life. Mt. Kisco, New York: Futura Publishing Co., 1973.
-
Sperry R. W. A modified concept of consciousness. Psychol. Rev., 76: 532-536, 1969.[Medline]
-
Stevens L. The development of transplantable teratocarcinomas from intratesticular grafts of pre- and post-implantation mouse embryos. Dev. Biol., 21: 364-382, 1970.[Medline]
-
Mintz B., Illmensee K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Natl. Acad. Sci. USA, 72: 3585-3589, 1975.[Abstract/Free Full Text]
-
Rubin H. Cancer as a dynamic developmental disorder. Cancer Res., 45: 2935-2942, 1985.[Free Full Text]
-
Parsons R., Li G-M., Longley M., Modrich P., Liu B., Berk T., Hamilton S. R., Kinzler K. W., Vogelstein B. Mismatch repair deficiency in phenotypically normal human cells. Science (Washington DC), 268: 738-740, 1995.[Abstract/Free Full Text]
-
Vijg J., Dollé M. E., Martus H-J., Boerrigter M. E. Transgenic mouse models for studying mutations in vivo: applications in aging research. Mech. Ageing Dev., 99: 257-271, 1997.[Medline]
-
Larson P. S., de las Morenas A., Cupples L. A., Huang K., Rosenberg C. L. Genetically abnormal clones in histologically normal breast tissue. Am. J. Pathol., 152: 1591-1598, 1998.[Abstract]
This article has been cited by other articles:

|
 |

|
 |
 
H. Rubin
Saturation Density of Skin Fibroblasts as a Quantitative Screen for Human Cancer Susceptibility
Cancer Epidemiol. Biomarkers Prev.,
September 1, 2009;
18(9):
2366 - 2372.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A Gatenby
Commentary: Carcinogenesis as Darwinian evolution? Do the math!
Int. J. Epidemiol.,
October 1, 2006;
35(5):
1165 - 1167.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Masramon, E. Vendrell, G. Tarafa, G. Capella, R. Miro, M. Ribas, and M. A. Peinado
Genetic instability and divergence of clonal populations in colon cancer cells in vitro
J. Cell Sci.,
April 15, 2006;
119(8):
1477 - 1482.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Nagai, H. Miyazawa, Huqun, T. Tanaka, K. Udagawa, M. Kato, S. Fukuyama, A. Yokote, K. Kobayashi, M. Kanazawa, et al.
Genetic Heterogeneity of the Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer Cell Lines Revealed by a Rapid and Sensitive Detection System, the Peptide Nucleic Acid-Locked Nucleic Acid PCR Clamp
Cancer Res.,
August 15, 2005;
65(16):
7276 - 7282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.-A. Risques, V. Moreno, M. Ribas, E. Marcuello, G. Capella, and M. A. Peinado
Genetic Pathways and Genome-Wide Determinants of Clinical Outcome in Colorectal Cancer
Cancer Res.,
November 1, 2003;
63(21):
7206 - 7214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Fornoni, O. Lenz, L. J. Striker, and G. E. Striker
Glucose Induces Clonal Selection and Reversible Dinucleotide Repeat Expansion in Mesangial Cells Isolated from Glomerulosclerosis-Prone Mice
Diabetes,
October 1, 2003;
52(10):
2594 - 2602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Baum, J. Dullmann, Z. Li, B. Fehse, J. Meyer, D. A. Williams, and C. von Kalle
Side effects of retroviral gene transfer into hematopoietic stem cells
Blood,
March 15, 2003;
101(6):
2099 - 2113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. R. Anderson, B. M. Brenner, H. Swede, N. Chen, W. M. Henry, J. M. Conroy, M. J. Karpenko, J.-P. Issa, J. D. Bartos, J. K. Brunelle, et al.
Intrachromosomal Genomic Instability in Human Sporadic Colorectal Cancer Measured by Genome-Wide Allelotyping and Inter-(Simple Sequence Repeat) PCR
Cancer Res.,
November 1, 2001;
61(22):
8274 - 8283.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Rubin
Selected Cell and Selective Microenvironment in Neoplastic Development
Cancer Res.,
February 1, 2001;
61(3):
799 - 807.
[Abstract]
[Full Text]
|
 |
|